Smoking Addiction: Neurobiology, Behavioral Patterns, and Cessation Strategies

Tobacco use disorder (DSM-5) = chronic, relapsing condition driven by nicotine's neuropharmacology and learned behaviors.

Neurobiology

  • Nicotine → α4β2 nicotinic ACh receptors → dopamine release in nucleus accumbens (reward)
  • Chronic exposure → upregulation, desensitization → tolerance, withdrawal
  • Cue-conditioning: contexts (coffee, break, alcohol) trigger craving via glutamate/dopamine

Dependence Dimensions

  • Physical: Withdrawal (irritability, anxiety, insomnia, concentration difficulty, hunger) peaks 2–3 days, lasts weeks
  • Psychological: Stress coping, identity, social ritual
  • Behavioral: Automaticity, cue-triggered

Evidence-Based Cessation

  • Combined pharmacotherapy + counseling = highest success
  • Meds: Varenicline (Chantix) > combination NRT > bupropion > single NRT
  • NRT: Patch + short-acting (gum/lozenge/inhaler) — 8–12 weeks
  • Counseling: CBT, motivational interviewing, quitlines (1-800-QUIT-NOW)
  • Relapse prevention: Identify triggers, coping skills, slip ≠ failure

Population-Specific

Pregnancy: NRT preferred; behavioral first. Mental illness: integrated treatment. Youth: counseling + NRT (off-label).

Most smokers require multiple attempts. Each attempt builds skills.

Drug Addiction - Related Articles